China Medical Robotics Industry Report, 2016-2020
- Hard Copy
- Single User License
- Enterprise-wide License
(PDF Printable & Editable)
- Hard Copy + Single User License
Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R & D priorities for China.
The overall development of Chinese medical robotics, in particular surgical robots, is relatively backward. In recent years, China has been dependent on Da Vinci products imported from the United States-based Intuitive Surgical. As of the end of December 2015, more than 40 Chinese hospitals had installed over 50 surgical robots for fulfilling 11,445 cases of surgery in 2015 and 22,917 cases over the years cumulatively. According to diseases, Da Vinci surgical system finds main application in urology and general surgical disciplines (hepatobiliary, pancreatic, gastrointestinal, colorectal and thyroid surgery, etc.) in China, and have implemented 9,313 and 7,220 cases so far respectively, occupying 40.6% and 31.5% of the total separately.
Surgery Cases Operated by Surgical Robots (Da Vinci) in China by end of 2015 (by Disease)
However, Chinese surgical robots have also made some progress with the support of the national policies and subsidies.
In July 2016, CFDA received Beijing TINAVI's registration application for its third-generation "Tianji" orthopedic surgery robot, which is expected to be formally commercialized at the end of 2016 or in early 2017. At present, TINAVI's orthopedic surgery robots have been applied to more than 10 hospitals such as Beijing Jishuitan Hospital, and have completed beyond 2,000 cases cumulatively.
In addition, Tianjin University has put its minimally invasive surgical robot system “Smart S” into clinical application and prototyped three models of “Smart S2” which are expected to be mass-produced at the end of 2016 or in 2017. Neurosurgical robot Remebot, the 6th-generation product co-developed by Navy General Hospital and Beihang University (Remebot responsible for industrialization) came out and was specially accepted for approval by CFDA in 2015 and is expected to be granted approval certificate at the end of 2016. Moreover, Remebot has started CE certification. The Laboratory of Robotics and System of Harbin Institute of Technology (affiliated companies: Boshi Automation and Harbin Sizherui Intelligent Medical Equipment Co., Ltd.) is expected to apply for product registration for its minimally invasive celiac surgical robot system at the end of 2017. Jinshan Science & Technology announced in Sept 2016 that the “minimally invasive thoracic & celiac surgical robot” co-developed with Tianjin University, Suzhou University, Harbin Institute of Technology, Chongqing University, and Southwest Hospital will go into clinical stage soon.
Due to low technical barriers and good market prospects, many Chinese enterprises have gotten involved in rehabilitation robot and dispensing robot fields and aggressive industrialization of these products. The enterprises focusing on rehabilitation robot include Jimho Robot (Shanghai), SIASUN Robot & Automation, Jinming Machinery, Truking Technology, and Midea Group and the ones on dispensing robot are Weibond Technology, Shenzhen Sanggu Medical Robot, and Wuxi Angel Medical Robot. However, it should be noted that these companies generally lack core technologies with less intelligent robots and need to spend large sums of money on R&D in the future.
China Medical Robotics Industry Report 2016-2020 highlights the following:
Operating environment for medical robotics in China (international markets, domestic policies, etc.);
Medical robot industry in China (status quo, competitive landscape, market segments (rehabilitation robot, surgical robot, dispensing robot), etc.);
6 overseas and 18 Chinese medical robot enterprises (operation, medical robot business, development prospects, etc.)
1. Overview of Medical Robotics
1.1.2 Medical Robotics
1.2 Industry Chain
2. Analysis on Operation Environment of Medical Robotics in China
2.1 Global Market Overview
2.1.1 Status Quo
2.1.2 Competition Pattern
3. Medical Robotics in China
3.2 Rehabilitation Medical Robotics
3.2.1 Increasingly-intensified Aging Trend
3.2.2 Huge Disabled Population
3.3 Surgical Robotics
3.4 Pharmacy Robotics
4. Major Medical Robotics Companies Worldwide
4.1 Intuitive Surgical, Inc.
4.1.3 Revenue Structure
4.1.4 Gross Margin
4.1.5 R&D Cost
4.2 Stryker Corporation
4.2.3 Revenue Structure
4.2.4 Gross Margin
4.2.5 R&D Cost
4.2.6 Medical Robotics Business
4.3 Ekso Bionics Holdings, Inc.
4.3.3 Revenue Structure
4.3.4 Gross Margin
4.3.5 R&D Cost
4.4 ReWalk Robotics Ltd.
4.4.3 Revenue Structure
4.4.4 Gross Margin
4.4.5 R&D Cost
4.5 Rex Bionics Plc
4.6 Mazor Robotics Ltd.
4.6.3 Revenue Structure
4.6.4 Gross Margin
4.6.5 R&D Cost
5. Major Medical Robotics Enterprises in China
5.1 Shenyang SIASUN Robot & Automation Co., Ltd.
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 Medical Robotics Business
5.1.6 Development Prospect & Forecast
5.2 Guangdong Jinming Machinery Co., Ltd.
5.2.3 Medical Robotics Business
5.3 Midea Group Co., Ltd.
5.3.3 Medical Robotics Business
5.4 Truking Technology Limited
5.4.3 Medical Robotics Business
5.5 Chongqing Dima Industry Co., Ltd.
5.5.3 Medical Robotics Business
5.6 Jinho Robot (Shanghai) Co., Ltd.
5.7 Shenzhen Mai Kangxin Medical Co., Ltd.
5.8 Anyang SF Robot Co., Ltd.
5.9 Beijing TINAVI Medical Technology Co., Ltd.
5.9.3 Medical Robotics Business
5.10 Harbin Boshi Automation Co., Ltd.
5.10.3 Medical Robotics Business
5.12 Smart Robot Technology Group Co., Ltd.
5.13 Jinshan Science & Technology (Group) Co., Ltd
5.13.2 Medical Robotics Business
5.14 Shanghai Taimi Robot Technology Co., Ltd.
5.15 ANKON Technologies Co., Ltd.
5.16 Shenzhen Weibond Technology Co., Ltd.
5.17 Shenzhen Sanggu Technology Co., Ltd.
5.18 Wuxi Anzhizhuo Medical Robot Co., Ltd.
Cost Structure of Robotics
Industrial Chain of Service Robotics
Core Modules and Technologies of Service Robotics
Enterprise Pattern of Global Service Robotics Industry
Medical Robotics Industry Development Plans of Major Countries
Sales Volume of Professional Service Robotics and YoY Growth Worldwide, 2009-2015
Proportion of Global Professional Service Robotics (by Sales Volume)
Sales Volume of Medical Robotics and YoY Growth Worldwide, 2009-2015
Regional Distribution of Global Medical Robotics Market
Global Medical Robotics Market Size, 2014/2015/2020E
Global Major Surgical Robot Enterprises and Their Products
China’s Plans on Robotics Industry, 2010-2016
Robotics Industry Parks in China and Planning Goal, 2014-2016
65-year-old (or above) Population in China and % in Total, 2009-2015
15 to 64-year-old Population’s Proportion in Total of China, 2009-2015
Average Family Size in China, 2009-2014E
Disabled Population’ Proportion in China’s Total by Type, 2010
Disposable Income of Urban and Rural Disabled Persons in China, 2007-2013
Engel Coefficient of Urban and Rural Disabled Persons in China, 2007-2013
Urban Disabled Persons’ Medical Healthcare Expenditures in China and % in Consumer Spending, 2007-2013
Rural Disabled Persons’ Medical Healthcare Expenditures in China and % in Consumer Spending, 2007-2013
Medical Robotics Configuration in Hospitals of Chinese Mainland, 2014
Quantity of Planned Medical Robotics in Hospitals of Chinese Mainland, 2015-2016
Hospitals with Over 1,000 Surgeries Operated by da Vinci Surgical Robot in China by the End of 2015
Number of Surgeries Operated by da Vinci Surgical Robot in China (by Disease) by the End of 2015
Revenue and Net Income of Intuitive Surgical, 2010-2016
Global Placement of da Vinci Surgical System (by Region) by the End of June 2016
Systems Placement of da Vinci Surgical System by Region, 2014-2016
Number of Surgeries Operated by da Vinci Surgical System (by Type), 2010-2016
Number of Surgeries Operated by da Vinci Surgical System (by Region), 2010-2016
Revenue of Intuitive Surgical (by Product), 2012-2016
Gross Margin of Intuitive Surgical, 2010-2016
R&D Cost and % of Total Revenue of Intuitive Surgical, 2012-2016
Revenue and Net Income of Stryker, 2009-2016
Revenue of Stryker by Product, 2009-2016
Repair Products’ Revenue Breakdown of Stryker by Application, 2012-2016
Medical System’s Revenue Breakdown of Stryker by Application, 2012-2016
Neural Technology & Spine Business’s Revenue Breakdown of Stryker by Application, 2012-2016
Gross Margin of Stryker, 2009-2016
R&D Costs and % of Total Revenue of Stryker, 2009-2016
Knee-joint and Hip-joint Systems of Makoplasty
Revenue of Ekso Bionics, 2011-2016
Net Income of Ekso Bionics, 2011-2016
Revenue of Ekso Bionics by Product, 2012-2016
Gross Margin of Ekso Bionics, 2012-2016
R&D Costs and % of Total Revenue of Ekso Bionics, 2012-2016
Revenue of Rewalk Robotics, 2012-2016
Net Income of Rewalk Robotics, 2012-2016
Revenue of Rewalk Robotics by Region, 2012-2016
Gross Margin of Rewalk Robotics, 2012-2016
R&D Costs and % of Total Revenue of Rewalk Robotics, 2012-2016
Global Operations of Rex Bionics
Revenue of Mazor, 2011-2016
Net Income of Mazor, 2011-2016
Revenue Structure of Mazor (by Business), 2010-2015
Products of Mazor (by Regional Installations), 2010-2016
Gross Margin of Mazor (by Business), 2011-2016
R&D Costs and % of Total Revenue of Mazor, 2011-2016
Revenue and Net Income of SIASUN, 2008-2015
Revenue and Gross Profit of SIASUN’s Industrial Robot Business, 2009-2014
Revenue and Net Income of SIASUN, 2014-2018E
Revenue and Net Income of Jinming Machinery, 2010-2015
Gross Margin of Jinming Machinery, 2010-2015
Revenue and Net Income of Midea Group, 2012-2015
Gross Margin of Midea Group, 2012-2015
Revenue and Net Income of Truking Technology, 2010-2015
Gross Margin of Truking Technology, 2010-2015
Revenue and Net Income of Dima Industry, 2010-2015
Gross Margin of Dima Industry, 2010-2015
Revenue and Net Income of Beijing TINAVI Medical Technology, 2013-2016
Service Robotics Revenue Structure of Beijing TINAVI Medical Technology (by Product), 2013-2015
Revenue and Net Income of Harbin Boshi Automation, 2010-2015
Gross Margin of Harbin Boshi Automation, 2010-2015
Distribution of Remebot’s Cooperative Hospitals
Medical Robotics Products of Jinshan Science & Technology
Development History of Taimi Robot
China Interferon Industry Report, 2016-2021
Interferon is mainly used for the treatment of hepatitis B, hepatitis C, multiple sclerosis, condyloma acuminatum and other diseases. Wherein, IFN-α is mainly suitable for curing hepatitis B and hepat...
China Hospital Industry Report,2016-2020
In recent years, "Opinions on Promoting the Development of Health Service Industry" and other related policies, the people’s growing awareness of health care and the acceleration of population aging h...
China Aged Care Industry Report, 2016-2020
China entered the aging society early in 1999. By the end of 2015, China’s population aged over 60 reached 222 million and the old-age dependency ratio 13.9%. By 2020, China’s population aged over 60 ...
China Medical Robotics Industry Report, 2016-2020
Medical robotics can be used in surgery, rescue, transport, care, rehabilitation, dispensing and so on for the sick and wounded. Especially, surgical, rehabilitation and dispensing robots are the R &a...
China Dental Industry Report, 2016-2020
The dental industry refers to medical industrial chain on the basis of oral medical consumption, consisting mainly of dental apparatus (equipments and consumables), dental medical services, etc. With ...
China Medical Imaging Diagnosis Industry Report, 2015-2019
Against the background of a surge in social demand, handsome profit and the favorable opportunity brought by health care reform, the medical imaging industry, especially medical imaging equipment indu...
China Heparin Industry Report, 2015-2018
As the world's largest heparin API producer and exporter, China seizes about 80% share of the global heparin API market. After the explosive growth in 2008-2010, the stagnant international market and ...
Global and China Stem Cell Industry Report, 2015-2018
Stem cells are undifferentiated biological cells that can differentiate into specialized cells and can divide (through mitosis) to produce more stem cells. Currently, stem cells are used to treat hund...
China Hospital Industry Report, 2015-2018
Stimulated by the demand, the number of hospitals in China rose from 21,979 in 2011 to 26,479 at the end of May 2015, an increase of 4,500 in total. Among them, public hospitals showed an overall decl...
China Independent Clinical Laboratory Industry Report, 2015-2018
The independent clinical laboratory originated from the U.S. and is relatively mature in developed countries/regions like North America, Europe, and Japan, whose independent clinical laboratory market...
China Medical Robot Industry Report, 2014-2018
Medical robots can be applied to surgeries, rescue, transport, nursing and rehabilitation of the sick and wounded. Wherein, surgery and rehabilitation robots are two striking market segments.
Due to ...
China Aged Care Industry Report, 2014-2017
According to the UN standard (the elderly people aged over 60 accounting for 10% of total population or the elderly people over age 65 occupying 7% of total population in one region), China entered th...
China Dental Industry Report, 2014-2018
Oral industry refers to the medical industry chain on the basis of oral medical consumption, mainly covering oral medical apparatus (equipment and consumables) and oral medical services. As reform of ...
China Medical Monitor Industry Report, 2014-2017
With advancement of medical reform, improvement of spending power, and enhancement of health care consciousness, China’s medical monitor industry is gradually expanding. During 2007-2013, the market s...
China Independent Clinical Laboratory Industry Report, 2014-2017
The independent clinical laboratory industry starts relatively late in China, featuring a limited overall size but high-speed development. In 2013 the independent clinical laboratory market size there...
China Interventional Cardiovascular Device Industry Report,2014-2017
The prevalence of cardiovascular disease in China impacted by accelerated aging of population and changes in consumption concept, dietary habit, way of working and other lifestyles has been growing ye...
China PTCA Balloon Market Investment Report, 2014-2016
PTCA balloon, as a indispensable medical device in percutaneous coronary intervention (PCI), serves not only as a delivery system for stent, but also as a device for pre-/post-stent dilatations. There...
China Orthopedic Instrument Industry Report, 2014-2017
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale ...